Annual report pursuant to Section 13 and 15(d)

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)

v3.10.0.1
Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2018
Notes Tables  
Schedule of Franchisor Disclosure [Table Text Block]
    Year Ended
 December 31,
Franchised clinics:   2018   2017
Clinics open at beginning of period    
352
      
309
  
Opened or Purchased during the period    
47
      
41
  
Acquired or sold during the period    
(1
 )    
6
  
Closed during the period    
(4
 )    
(4
 )
Clinics in operation at the end of the period    
394
      
352
  
    Year Ended
 December 31,
Company-owned or managed clinics:   2018   2017
Clinics open at beginning of period    
47
      
61
  
Opened during the period    
–
      
–
  
Acquired during the period    
1
      
–
  
Closed or Sold during the period    
–
      
(14
 )
Clinics in operation at the end of the period    
48
      
47
  
                 
Total clinics in operation at the end of the period    
442
      
399
  
                 
Clinic licenses sold but not yet developed    
136
      
104
  
Executed letters of intent for future clinic licenses    
19
      
8
  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
    Year Ended
 December 31,
    2018   2017
        (as adjusted)
Net income (loss)   $
253,083
     $
(3,432,412
 )
                 
Weighted average common shares outstanding - basic    
13,669,107
      
13,245,119
  
Effect of dilutive securities:                
Unvested restricted stock and stock options    
362,609
      
–
  
Weighted average common shares outstanding - diluted    
14,031,717
      
13,245,119
  
                 
Basic earnings (loss) per share   $
0.02
     $
(0.26
 )
Diluted earnings (loss) per share   $
0.02
     $
(0.26
 )
    Year Ended
 December 31,
    2018   2017
Unvested restricted stock    
24,180
      
63,700
  
Stock options    
651,036
      
1,003,916
  
Warrants    
–
      
90,000
  
Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block]
    As of
December 31, 2017		   Adjustments Due
to ASC 606
adoption		   As of
December 31, 2017
ASSETS  
(as reported)
  
 
  
(as adjusted)
Current assets:                        
Deferred franchise costs - current portion   $
484
 
   $
14
     $
498
 
Total current assets    
6,657
 
    
14
      
6,671
 
Deferred franchise costs, net of current portion    
813
 
    
1,500
      
2,313
 
Deposits and other assets    
612
 
    
12
      
623
 
Total assets   $
16,910
 
   $
1,526
     $
18,436
 
                         
LIABILITIES AND STOCKHOLDERS' EQUITY                        
Current liabilities:                        
Deferred franchise revenue - current portion   $
1,686
 
   $
308
     $
1,994
 
Other current liabilities    
49
 
    
104
      
153
 
Total current liabilities    
4,967
 
    
412
      
5,379
 
Deferred revenue, net of current portion    
4,693
 
    
4,859
      
9,553
 
Total liabilities    
12,011
 
    
5,271
      
17,283
 
Stockholders' equity:                        
Accumulated deficit    
(32,259
)
    
(3,745
 )    
(36,004
)
Total stockholders' equity    
4,899
 
    
(3,745
 )    
1,153
 
Total liabilities and stockholders' equity   $
16,910
 
   $
1,526
     $
18,436
 
    Year Ended
December 31, 2017		   Adjustments Due
to ASC 606
adoption		   Year Ended
December 31, 2017
    (as reported)       (as adjusted)
Revenues:                        
Franchise fees   $
1,442
     $
(61
 )   $
1,382
  
Regional developer fees    
584
      
(185
 )    
399
  
Total revenues    
25,164
      
(245
 )    
24,919
  
Cost of revenues:                        
Franchise cost of revenues    
2,997
      
(88
 )    
2,909
  
Total cost of revenues    
3,312
      
(88
 )    
3,224
  
Loss from operations    
(3,175
 )    
(157
 )    
(3,332
 )
Loss before income tax expense    
(3,239
 )    
(157
 )    
(3,397
 )
Net loss and comprehensive loss   $
(3,275
 )   $
(157
 )   $
(3,432
 )
                         
Loss per share:                        
Basic and diluted loss per share   $
(0.25
 )   $
(0.01
 )   $
(0.26
 )